These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 14717670)
1. Prognostic value of immunohistochemical expression of p53, bax, Bcl-2 and Bcl-xL in resected non-small-cell lung cancers. Groeger AM; Esposito V; De Luca A; Cassandro R; Tonini G; Ambrogi V; Baldi F; Goldfarb R; Mineo TC; Baldi A; Wolner E Histopathology; 2004 Jan; 44(1):54-63. PubMed ID: 14717670 [TBL] [Abstract][Full Text] [Related]
2. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung. Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189 [TBL] [Abstract][Full Text] [Related]
3. Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer. Borner MM; Brousset P; Pfanner-Meyer B; Bacchi M; Vonlanthen S; Hotz MA; Altermatt HJ; Schlaifer D; Reed JC; Betticher DC Br J Cancer; 1999 Feb; 79(5-6):952-8. PubMed ID: 10070896 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer. Apolinario RM; van der Valk P; de Jong JS; Deville W; van Ark-Otte J; Dingemans AM; van Mourik JC; Postmus PE; Pinedo HM; Giaccone G J Clin Oncol; 1997 Jun; 15(6):2456-66. PubMed ID: 9196162 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical demonstration of apoptosis-regulated proteins, Bcl-2 and Bax, in resected non-small-cell lung cancers. Hanaoka T; Nakayama J; Haniuda M; Sato TA Int J Clin Oncol; 2002 Jun; 7(3):152-8. PubMed ID: 12109516 [TBL] [Abstract][Full Text] [Related]
6. Accelerated apoptosis and low bcl-2 expression associated with neuroendocrine differentiation predict shortened survival in operated large cell carcinoma of the lung. Eerola AK; Ruokolainen H; Soini Y; Raunio H; Pääkkö P Pathol Oncol Res; 1999; 5(3):179-86. PubMed ID: 10491014 [TBL] [Abstract][Full Text] [Related]
7. BAX and p16INK4A are independent positive prognostic markers for advanced tumour stage of nonsmall cell lung cancer. Gessner C; Liebers U; Kuhn H; Stiehl P; Witt C; Schauer J; Wolff G Eur Respir J; 2002 Jan; 19(1):134-40. PubMed ID: 11843312 [TBL] [Abstract][Full Text] [Related]
8. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer. Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766 [TBL] [Abstract][Full Text] [Related]
9. Expression of apoptosis-regulating proteins p53, Bcl-2, and Bax in primary resected esophageal squamous cell carcinoma. Hsia JY; Chen CY; Hsu CP; Shai SE; Yang SS; Chuang CY; Wang PY; Chen JT Neoplasma; 2001; 48(6):483-8. PubMed ID: 11949842 [TBL] [Abstract][Full Text] [Related]
10. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis. Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of apoptosis in breast cancer (pT1-pT2). A TUNEL, p53, bcl-2, bag-1 and Bax immunohistochemical study. Sirvent JJ; Aguilar MC; Olona M; Pelegrí A; Blázquez S; Gutiérrez C Histol Histopathol; 2004 Jul; 19(3):759-70. PubMed ID: 15168338 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of bax associated with mutations in the loop-sheet-helix motif of p53. Huang C; Kohno N; Inufusa H; Kodama K; Taki T; Miyake M Am J Pathol; 1999 Sep; 155(3):955-65. PubMed ID: 10487853 [TBL] [Abstract][Full Text] [Related]
13. Does immunointensity account for the differences in prognostic significance of Bcl-2 expression in non-small cell lung cancer? Cox G; Walker RA; Muller S; Abrams KR; Steward WP; O'Byrne KJ Pathol Oncol Res; 2000; 6(2):87-92. PubMed ID: 10938137 [TBL] [Abstract][Full Text] [Related]
14. [Prognostic value of expression of FASE, HER-2/neu, bcl-2 and p53 in stage I non-small cell lung cancer]. Wang Y; Zhang XR; Fu J; Tan W; Zhang W Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):369-72. PubMed ID: 15312350 [TBL] [Abstract][Full Text] [Related]
15. Association of smoking with apoptosis-regulated proteins (Bcl-2, bax and p53) in resected non-small-cell lung cancers. Hanaoka T; Nakayama J; Mukai J; Irie S; Yamanda T; Sato TA Int J Cancer; 2001 Jan; 91(2):267-9. PubMed ID: 11146457 [No Abstract] [Full Text] [Related]
16. Expression of Bcl-2, Bax, and p53 proteins in carcinogenesis of squamous cell lung cancer. Chen Y; Sato M; Fujimura S; Endo C; Sakurada A; Aikawa H; Takahashi H; Tanita T; Kondo T; Saito Y; Sagawa M Anticancer Res; 1999; 19(2B):1351-6. PubMed ID: 10365105 [TBL] [Abstract][Full Text] [Related]
17. The interactive effect of Ras, HER2, P53 and Bcl-2 expression in predicting the survival of non-small cell lung cancer patients. Kim YC; Park KO; Kern JA; Park CS; Lim SC; Jang AS; Yang JB Lung Cancer; 1998 Dec; 22(3):181-90. PubMed ID: 10048471 [TBL] [Abstract][Full Text] [Related]
18. Tissue microarray analysis of Fas and FasL expressions in human non-small cell lung carcinomas; with reference to the p53 and bcl-2 overexpressions. Myong NH J Korean Med Sci; 2005 Oct; 20(5):770-6. PubMed ID: 16224150 [TBL] [Abstract][Full Text] [Related]
19. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse. Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743 [TBL] [Abstract][Full Text] [Related]